Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Endogyne Oy
OY
Dissolved
Y-tunnus 2078794-7
A B 31, 20100
Turku
Other human health activities n.e.c.
·
NACE 8699
Est. 2006 · 19 years old
1 employees
Share
Finland
/
Companies
/
Other human health activities n.e.c.
/
Endogyne Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
7M
13M
20M
26M
0M
2021
0M
2022
0M
2023
23M
2024
0M
2025
EBITDA
EUR millions
19M
14M
9M
5M
0M
0M
2021
0M
0%
2022
0M
0%
2023
15M
+1500%
2024
0M
-100%
2025
Income statement
EUR thousands
Item
2021
2022
2023
2024
2025
Revenue
263
258
247
22 826
273
Staff expenses
−32
−36
−48
−3 149
−40
EBITDA
228
178
156
14 946
181
Depreciation & amort.
−13
−9
−7
−495
−4
EBIT
215
169
150
14 450
177
Net financials
0
1
1
1 758
5
Profit before tax
216
170
151
16 208
182
Tax
34
39
31
32
37
Net profit
182
131
120
12 966
146
Balance sheet
EUR thousands
Item
2021
2022
2023
2024
2025
Total assets
1 077
1 131
1 152
1 191
1 248
Equity
1 065
1 112
1 143
1 181
1 233
Long-term debt
—
—
0
0
0
Short-term debt
11
19
9
945
16
Total debt
11
19
9
9
16
Financial ratios
5-year trend
EBITDA margin
66.2%
This company
15.8%
Market median
+319% vs market
2021
2025
Equity ratio
98.7%
This company
38.2%
Market median
+158% vs market
2021
2025
Return on equity
11.8%
This company
18.4%
Market median
+36% vs market
2021
2025
Net profit margin
53.4%
This company
8.1%
Market median
+559% vs market
2021
2025
Asset turnover
0.22×
This company
1.12×
Market median
-80% vs market
2021
2025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2024-09-01 – 2025-08-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2023-09-01 – 2024-08-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2022-09-01 – 2023-08-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2021-09-01 – 2022-08-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2020-09-01 – 2021-08-31
View
PDF
More on Endogyne Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network